Nephrotic syndrome risk factors: Difference between revisions
Line 10: | Line 10: | ||
==Overview== | ==Overview== | ||
==risk factors== | ==Risk factors== | ||
Risk factors of nephrotic syndrome depend on the type of syndromes as below: | |||
Common risk factors in the development of minimal change disease include:<ref name="IijimaHamahira20022">{{cite journal|last1=Iijima|first1=Kazumoto|last2=Hamahira|first2=Kiyoshi|last3=Tanaka|first3=Ryojiro|last4=Kobayashi|first4=Akiko|last5=Nozu|first5=Kandai|last6=Nakamura|first6=Hajime|last7=Yoshikawa|first7=Norishige|title=Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome|journal=Kidney International|volume=61|issue=5|year=2002|pages=1801–1805|issn=00852538|doi=10.1046/j.1523-1755.2002.00303.x}}</ref> | |||
* Children within the Age >1 year but <8 years | |||
* Hodgkin lymphoma | |||
* Leukemia | |||
* Recent viral illness | |||
* Toxins such as mercury, bee stings, fire coral exposure are one of the causes for minimal change disease. | |||
* Medication such as<ref name="pmid279404603">{{cite journal |vauthors=Vivarelli M, Massella L, Ruggiero B, Emma F |title=Minimal Change Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=2 |pages=332–345 |date=February 2017 |pmid=27940460 |pmc=5293332 |doi=10.2215/CJN.05000516 |url=}}</ref> | |||
**Salazopyrin | |||
** Salazopyrin | |||
** Mercury | |||
** Tiopronin | |||
** Lithium | |||
** D-penicillamine | |||
** Gold | |||
** Tyrosine-kinase inhibitor | |||
The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):<ref name="FSGS">{{cite web |url= http://cdn.intechopen.com/pdfs/22820/InTech-Focal_segmental_glomerulosclerosis.pdf|title= Focal segmental glomerulosclerosis.|last1= Sohal |first1= DS |last2= Prabhakar |first2= SS |date=November 02, 2011|website= Interchopen |publisher= InTech |accessdate=3 December 2013}}</ref> | |||
* Male gender | |||
* Black race | |||
* Family history | |||
* Heroin abuse | |||
* Drugs known to be associated with FSGS | |||
* Chronic viral infection | |||
* Solitary kidney | |||
* Obesity | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 18:38, 16 May 2018
Nephrotic Syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Nephrotic syndrome risk factors On the Web |
American Roentgen Ray Society Images of Nephrotic syndrome risk factors |
Risk calculators and risk factors for Nephrotic syndrome risk factors |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Nephrotic Syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Nephrotic syndrome risk factors On the Web |
American Roentgen Ray Society Images of Nephrotic syndrome risk factors |
Risk calculators and risk factors for Nephrotic syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian
Overview
Risk factors
Risk factors of nephrotic syndrome depend on the type of syndromes as below:
Common risk factors in the development of minimal change disease include:[1]
- Children within the Age >1 year but <8 years
- Hodgkin lymphoma
- Leukemia
- Recent viral illness
- Toxins such as mercury, bee stings, fire coral exposure are one of the causes for minimal change disease.
- Medication such as[2]
- Salazopyrin
- Salazopyrin
- Mercury
- Tiopronin
- Lithium
- D-penicillamine
- Gold
- Tyrosine-kinase inhibitor
The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):[3]
- Male gender
- Black race
- Family history
- Heroin abuse
- Drugs known to be associated with FSGS
- Chronic viral infection
- Solitary kidney
- Obesity
References
- ↑ Iijima, Kazumoto; Hamahira, Kiyoshi; Tanaka, Ryojiro; Kobayashi, Akiko; Nozu, Kandai; Nakamura, Hajime; Yoshikawa, Norishige (2002). "Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome". Kidney International. 61 (5): 1801–1805. doi:10.1046/j.1523-1755.2002.00303.x. ISSN 0085-2538.
- ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). "Minimal Change Disease". Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
- ↑ Sohal, DS; Prabhakar, SS (November 02, 2011). "Focal segmental glomerulosclerosis" (PDF). Interchopen. InTech. Retrieved 3 December 2013. Check date values in:
|date=
(help)